BioNTech SE : Strong balance sheet to help leverage mRNA platform
>Comirnaty revenue short of previous expectations – strong cash position helps - Following an analyst change, we have updated our earnings model and reduced our TP to $ 140. The updated earnings model now reflects a more significant decline in demand for Covid-19 vaccines, driven by fewer primary vaccinations, lower levels of boosting and the expected transition from an advanced purchase agreement environment to a more market-driven order behaviour. At the same time t...
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.